ARAY Logo

Accuray Incorporated (ARAY) 

NASDAQ
Market Cap
$186.05M
Sector
Healthcare
Industry
Medical—Specialties
Rank in Sector
262 of 960
Rank in Industry
2 of 2

Largest Insider Buys in Sector

ARAY Stock Price History Chart

ARAY Stock Performance

About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, …

Insider Activity of Accuray Incorporated

Over the last 12 months, insiders at Accuray Incorporated have bought $156,045 and sold $97,459 worth of Accuray Incorporated stock.

On average, over the past 5 years, insiders at Accuray Incorporated have bought $168,894 and sold $420,367 worth of stock each year.

Highest buying activity among insiders over the last 12 months: WHITTERS JOSEPH E (director) — $624,180.

The last purchase of 50,000 shares for transaction amount of $79,000 was made by WHITTERS JOSEPH E (director) on 2024‑05‑29.

List of Insider Buy and Sell Transactions, Accuray Incorporated

2024-09-04SaleSVP Chief Financial Officer
8,404
0.0086%
$2.06$17,276-5.45%
2024-06-04SaleSVP Chief Financial Officer
2,701
0.0027%
$1.70$4,597+10.23%
2024-05-29Purchasedirector
50,000
0.0504%
$1.58$79,000+18.99%
2024-05-28Purchasedirector
50,000
0.0488%
$1.54$77,045+18.24%
2024-03-01SaleSenior VP Global Operations
11,991
0.012%
$2.59$31,057-26.82%
2024-01-03SaleSVP Chief Financial Officer
2,116
0.0022%
$2.74$5,800-23.76%
2024-01-03SaleVP, CAO and Controller
14,129
0.0147%
$2.74$38,729-23.76%
2023-12-01SalePresident
65,390
0.0661%
$2.47$161,624-13.66%
2023-12-01SaleSVP, Chief Commercial Officer
14,585
0.0147%
$2.47$36,041-13.66%
2023-12-01SaleSVP, Chief Commercial Officer
26,799
0.0186%
$1.70$45,612-13.66%
2023-12-01SaleSVP Chief Financial Officer
13,463
0.0136%
$2.47$33,271-13.66%
2023-12-01SaleSenior VP Global Operations
19,212
0.0194%
$2.47$47,482-13.66%
2023-12-01SaleSVP, General Counsel
29,770
0.0301%
$2.47$73,565-13.66%
2023-12-01SaleSVP, Chief Admin Officer
14,832
0.015%
$2.47$36,653-13.66%
2023-11-01SalePresident
38,338
0.0397%
$2.57$98,529-8.95%
2023-10-31SaleSVP Chief Financial Officer
3,303
0.0033%
$2.58$8,534-10.98%
2023-10-03SalePresident
17,119
0.0174%
$2.62$44,843-4.33%
2023-10-03SaleSenior VP Global Operations
8,353
0.0085%
$2.62$21,881-4.33%
2023-10-03SaleSVP, General Counsel
9,026
0.0092%
$2.62$23,644-4.33%
2023-10-03SaleSVP, Chief Admin Officer
5,863
0.006%
$2.62$15,358-4.33%

Insider Historical Profitability

<0.0001%
WHITTERS JOSEPH Edirector
561053
0.5579%
$1.8580<0.0001%
Winter Suzanne CPresident
1369811
1.3621%
$1.85110<0.0001%
LEVINE JOSHUACEO
1088480
1.0824%
$1.85616+1.51%
Wu Waynedirector
561075
0.5579%
$1.8521<0.0001%
Londy KellyEVP Chief Operating Officer
396601
0.3944%
$1.8514+15.24%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$19.98M8.158.09M-2.48%-$507,933.27<0.0001
Archon Capital Management Llc$16.09M6.566.51M0%+$00.36
Neuberger Berman$14.35M5.865.81M+5.78%+$784,120.280.01
The Vanguard Group$12.96M5.295.25M-0.41%-$53,477.97<0.0001
ROYCE & ASSOCIATES INC$8.09M3.33.27M+1.28%+$102,117.210.07
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.